Rex Health Ventures — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
BioStable Science & EngineeringFeb 2020
Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement.
Austin, US
John Wheeler(Executive Officer, Director)Joe Cunningham(Director)David Adair(Director)David Strong(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.